SEC Form D · Amendment · filed January 4, 2017
Lodo Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Misti J. Ushio · New York, NYDirectorAsish Xavier · New York, NYDirectorM. J. Erwin · New York, NYDirectorLindsay J. Rayle · New York, NYExec · PromoterSteve Gillis · New York, NYDirectorJames J. Sullivan · New York, NYDirectorJoel J. Marcus · New York, NYDirectorDavid J. Mcelligott · New York, NYExec · PromoterDavid J. Schubert · New York, NYExec · PromoterBarbara J. Dalton · New York, NYDirectorThong Le · New York, NYExec · Director · PromoterDavid J. Mcelligott · New York, NYExec · PromoterWilliam P. Dambrackas · Weston, FLDirectorHoward C. Glick · Linden, TXDirectorBryan Darroch · Grand Cayman, Cayman IslandsDirectorLindsay J. Rayle · New York, NYExec · PromoterFernando E. Alcoceer · Vancouver, British Columbia, CanadaExec · Director · PromoterWilliam D. Pruitt · Coral Gables, FLDirectorNancy R. Fuller · Linden, TXDirectorDavid J. Pompliano · New York, NYExecJane E. Trust · Baltimore, MDDirectorRichard F. Sennett · Baltimore, MDExec · Director · PromoterThomas C. Mandia · Stamford, CTExec · Director · PromoterBenjamin E. Seidlich · Baltimore, MDExec · PromoterRobert I. Frenkel · Stamford, CTExec · PromoterS. C. Bain · Phoenix, AZDirectorJay E. Wolf · Phoenix, AZDirectorLawrence D. Bain · Phoenix, AZDirectorDavid E. Smith · Phoenix, AZDirectorMarc Rubenstein · Phoenix, AZExec · PromoterGeorge Mccabe · Boston, MADirectorDavid J. Pompliano · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗